TP53 and type 2 diabetes mellitus: Our results are consistent with the seminal study by Minamino et al. who demonstrated the key role of the p53/p21 pathway in the induction of premature senescence in the AT in both of obese and insulin‐resistant mice and in that of T2D patients.